Member Info for Aldebaran

Erm... anyone seen that trade printed late today?

Pumpkin if MDA are controlling what Vlad can say and thats a big IF, because Avacta also have trials there and can seemingly communicate 10x more than HEMO, then why was Vlad allowed to tell us the patience were alive in August but couldn't tell us in September? Don't you find that odd or am I concerned about nothing? What possible explanation is there for that?

Also, info needed is some forward looking timescales, why can't Vlad tell us that he expects safety review to take X weeks, then he expects patient selection to take Y weeks, and finally next dose escalation in Z weeks or give approximate timelines. The market needs some visibility and thats why its sold off.

With no further news or worse bad news then the market will sell of and all or most of the gains weve made will be lost. That means then when the next bit of good news comes we dont get past recent high. All well and good except if Vlad doesn't commercialise this thing before cash runs out then there's another placing coming.

People can talk all they want about Estonia. Ultimately its a non binding letter of intent. Zero guarantees anything materialises from this. If it does materialise it won't be until next year and then what will be revenue split with Celline etc etc.. all going to take time to ramp up and therefore in my view a placing will be required if Vlad hasn't partnered HG-CT-1 or sold off or whatever and in that scenario we all surely want it to be at the highest price possible to minimise dilution.

People saying they dont want news because it benefits traders have lost the plot.

We need news and we need it soon otherwise I see 500p coming - dont shoot the messenger especially when you all laughed at me for suggesting 1000p would come.

He's parroting what he's heard from Tom Winnifrith podcast thats all. Hasn't bothered to even cross check what Tom has said ha

Leave him to it BV, he's not affecting anything and will likely lose a fortune through his own ignorance 🤷‍♀️

I couldn't give a 💩

Chris, i was banned for 5 days recently so didnt post. I posted a few messages then haven't bothered for past 3 days so I wouldn't say i comment on everything.

I post today that I believe HEMO to be grossly undervalued and I want the CEO to come out and do more PR and show investors what we have to look forward too and even that seems controversial. Like Trump derangement syndrome you lot have Alde derangement syndrome.

I mention Avacta as an ideal comparison, recently people have been slating me here for NOT mentioning Avacta haha.

Avacta and hemo have lot of similarities and can learn from each other. Well, hemo can learn from avacta I should say. Why cant Vlad release a spotlight series for example? Costa nothing and its highly engaging to shareholders, new and old. What is wrong with comparing the 2 companies and making suggestions for how each one could improve?

Its like you're all scared to even mention avacta because you know it to be a far superior investment and you're heavily underwater here do dint want anyone seeing the light and switching over. Thats my feel though I dont believe that will happen personally its why I dont give a shhh it if and when any of you post on avacta board. I think its good for us all to share and learn

JHFH, as well traders don't need or use fundamental information. If something big is happening it will be evident in the price action.

Recall me saying if this brakes above 180p with volume it would be a buy signal? Zero fundamenta news needed to back that up. Could see it on the chart.

Remember I said warrants not been forward sold, could see it in the price action.

Remember I said at 1600p this would fall to 1000p?

None of that require any fundamentals info. You have advised vlad to run this like a private company which is a mistake in my view. He needs to be more open and transparent to onboard new investors and especially institutions. Traders don't need anything from you. Sorry to burst your bubble

Perhaps its exactly this reason those at DC/NCY haven't jumped in head first. It's a PLC, investors particular institutions want some visibility of timelines not guarantees of clinical results which nobody can know.

As a PLC JHFH you have to accept people trade and invest on there own timelines. Not everyone wants to buy and hold forever like you seemingly believe they should.

Archbishop, like the other zealots before you you have selectively chosen my quotes. I went on to say a big buy signal would be price breaking 180p with volume. Which it did so I brought. I then said the top would be around 1600p which it was. I then said warrants weren't forward sold which they weren't. I then said this would pull back to 1000p which it did.

And at the same time (23rd September) when the share price was 1,580 you posted this banger...

"This floor is feeling really solid. Rats and mice under the floor boards nailed in"

😅 🤡

You have zero credibility hun so id pipe down if I were you

Also JHFH, it doesn't cost much in PR for Vlad to release some home made videos. You just buy a video camera and upload to YouTube.

You seem absolutely obsessed with traders and shorters. To your own detriment I feel now.

Im not asking Vlad to ramp anything, just be upfront and forthcoming with his communications. It helps to bring on board new investors.

I think for you at 7m market cap, you would have been better using your money to take hemo private by the way your talking

Archbishop no offence but your the guy who was saying hemo forming a base at 1,500p, 3 days later it was 30% cheaper and been around here ever since. You also say avacta aren't creators yet dont seem to understand the difference between foundational IP and the company's nee IP which they have created and protected until 2045. You have zero credibility so shhhh.

JHFH, i think HEMO could perform well over next few months and a commercial deal will land in Q1 2026 but timelines and transparency are important for investors mainly and especially institutions. Traders will use charts and price action so its irrelevant to them/us.

JhFH, be honest with me, you want more from Vlad right? You surely see my point about him needing to engage more and drive value in the company in shortest possible time. A higher valuation gives so much more optionality and flexibility.

Haha JHFH I didnt realise that. Maybe they dont post much!

Good find though super sleuth ;-)

Is not a competition JHFH and Avacta sold their revenue generating business already lol

I think HEMO and Avacta will both be brought out next year. I dont think the Estonia deal will have any material impact on HEMO unless it isnt brought out and it has over come many obstacles and ramped up which won't be until middle of next year.

Let it roll, nobody at avacta has the name "hereonly4avacta" etc nor do they end every post with go avacta go.

If anyone is in love with a share its you lot with hemo.

Science is great, needs a lot of work is all im saying and comparing to other similar companies is a useful exercise. Many of you laughed at my 60k holding so you must have eye watering amounts of money in here. I'd have thought you'd be putting much more pressure on the CEO to get the valuation up to something more sensible yet you seem content with it. Strange.

And what is even weirder is that if anyone dare to point it out here on this public discussion board they are ostracised or ridiculued. I want hemo value UP and the CEO is responsible for that. He's simply not delivering. He's a scientist and should step aside imo. Having great science is where avact and hemo end their commonality. Avacta is lightyears ahead in almost every other aspect. I want hemo to catch up. Don't you?

Troll?

Im just comparing 2 companies. Both small caps. Both biotechs. Both have amazing science. Both release interim on same day.

Avacta delivered there's with an investor webinar and was presented by CEO and CFO...

Hemo... we got an RNS only.

Its not trolling to say that Hemo need to do much better in this regard. Its not all about the science. I believe HEMO is undervalued and I want the executive team to unlock that value. Isn't going to happen anytime soon if they don't start improving in other aspects apart from the science.

At this rate another fund raise will come before commercialisation and you'll all be saying I was right he should of raised at 1700p the other week etc...

What is Vlads plan for investor engagement????

That recent video from Vlad was poor IMO.

Note interim released for Avacta and Hemo on same day and avacta up almost 30% with volume and hemo still treading water here around 1000p despite supposedly having pediatrics imminent.

Both have exquisite science but Avacta have a much better management team. Along with the interim report the avacta CEO has spelt out clear timelines of major events clinical and pre clinical data releases, future investor events and gave strong hints at imminent commercialisation. Hemo... silence. Vlad just spoke a bit about the non binding letter of intent in Estonia and nothing else. He told us in August patients were still alive but not a word now. Why? What do the timelines look like on safety data review and adult 2nd cohort. When will pediatrics start? Is there any positive news from DC or NYC etc etc...

Not good enough. He's a scientist not a CEO and its why we're still treading water despite having seemingly exquisite science.

Price gapped open again today...

Volume is there. This is about to go on a big run IMO.

Fundamentals and technicals aligned which is a huge plus

Its not about what the offer is related to our market cap its about what the offer is related to intrinsic value.

I agree with ICE in that the market and aim in particular is schizophrenic I mean how can this vary so much over the past few years? At no point has the valuation ever made sense. Back in 2020 it was way over valued and today it is way undervalued.

I think naturally BP will want this for as cheap as possible but I dont think they'll take into account the AIM valuation at the time. With 2 big pharma or more bidding then the aim valuation becomes even more irrelevant.

Might be the only opportunity in our lives to make the kind of money this platform is worth. Take that opportunity with both hands.

United if you know very little about shares, you shouldn't be investing. Especially in high risk small cap biotechs.

Coming on here a asking random and annonymous bulletin board members what the share price will be is a daft question.

What i suggest you do is look up the Total Addressable Market, the chance of success (10% standard) & use a DCF model to backwork what the company should be worth today. If you do that and the current value is less than what you calculate it to buy (hint, it is), then you would consider taking a position then cashing out at a point in future for a profit.

Another note about the chart which I just noticed is that price gapped open high this morning AND it is trading just about at the 1 year high. In addition to the other points I raise earlier these are additional bullish signals which indicate avacta share price is about to go on a run

On the daily price has bounced off 50ma strongly

Some chunky buys gone through today £100k+

High volume and already popped above recent high

100ma about to cross 200ma then we have COMA (Correct Order Moving Averages)

RSI looking strong

Candles are bullish

I see high 80's as next natural stop point from technical POV but with so much news due who knows. On some kind of commercial deal id expect all time high.

Great risk reward here

Your a parasite wyn. Your post negativity or positivity reflect your trading position only.

Patent life i mean